- COVID Vaccination and Myeloproliferative NeoplasmsCOVID Vaccine effectiveness data for MPN's now available
- Datopotamab Deruxtecan Promising in Triple Negative Breast CancerDatopotamab Deruxtecan Promising in Triple Negative Breast Cancer
- Cryoablation Emerging as Effective Treatment for Low Risk Breast CancersCould freezing temperatures be the next treatment for breast cancer?
- Jakafi Rechallenge May Improve Survival in Patients with MyelofibrosisUsing Jakafi a second time may benefit patients with Myelofibrosis.
- A High-Fiber Diet Does Not Reduce Risk for Colorectal CancerA High-Fiber Diet Does Not Reduce Risk for Colorectal Cancer
- Zynlonta (loncastuximab tesirine) ADC for Non-Hodgkin LymphomaFDA grants accelerated approval to Zynlonta, a novel Anitbody Drug Conjugate for the treatment relapsed/refractory large B-cell lymphoma
- Low-Dose Xeloda After Surgery for Triple-Negative Breast Cancer Reduces Recurrence RiskLow dose Xeloda reduces the risk of TNBC recurrence
- Diets Low in Fruits, Vegetables and Fiber May Increase Colon Cancer RiskDiets Low in Fruits, Vegetables and Fiber May Increase Colon Cancer Risk
- Imbruvica® Effective in Newly Diagnosed & Recurrent Chronic Lymphocytic LeukemiaImbruvica® Rituxan combination superior to FCR chemotherapy for treatment of newly diagnosed CLL
- P-Selectin (SELP) and GlioblastomaResearch Breakthrough - Activating the brain's immune system against cancer prevents it from spreading .
